Skip to main content
CARCLO PLC logo

CARCLO PLC — Investor Relations & Filings

Ticker · CAR ISIN · GB0001751915 LEI · 21380078MEM399JPI956 IL Manufacturing
Filings indexed 558 across all filing types
Latest filing 2018-07-10 Regulatory Filings
Country GB United Kingdom
Listing IL CAR

About CARCLO PLC

http://www.carclo-plc.com/

Carclo PLC is a global precision engineering group that designs, industrializes, and manufactures high-reliability solutions and complex components. The company specializes in fine-tolerance, injection-molded plastic parts and multi-component assemblies. Its core competencies encompass the entire production lifecycle, from initial design, engineering, and mold creation to advanced manufacturing processes like precision injection molding and automated assembly. Carclo provides comprehensive supply chain solutions, serving demanding, precision-focused markets including Life Sciences, Aerospace, Optics, and other advanced technology sectors. Key product areas include components for in-vitro diagnostics, drug delivery systems, and advanced optical systems.

Recent filings

Filing Released Lang Actions
Form 8.3 - Carclo plc
Regulatory Filings Classification · 98% confidence The document is explicitly labeled as an 'RNS Number' and contains a 'FORM 8.3' titled 'PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE' under 'Rule 8.3 of the Takeover Code'. This form relates to insider dealing/ownership disclosure during a takeover scenario. While it details director/insider transactions (which might suggest DIRS), the specific format (Form 8.3) and the context of the Takeover Code strongly indicate a regulatory filing related to market activity, often disseminated via an RNS service. Since 'Director's Dealing' (DIRS) is usually for routine insider transactions (Form 3, 4, 5 equivalent in the US context, or similar national forms), and this is a specific disclosure mandated by the Takeover Code, it fits best under the general 'Regulatory Filings' (RNS) category, as it is a mandatory public disclosure to a Regulatory Information Service (RNS) about interests in securities during an offer period. It is not a standard earnings release, annual report, or management discussion.
2018-07-10 English
Form 8.3 - carclo plc
Director's Dealing Classification · 98% confidence The document is explicitly titled 'FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE' and references 'Rule 8.3 of the Takeover Code'. This form relates to insider dealings or significant ownership changes during a takeover scenario. This specific type of disclosure, which reports personal share transactions by executives or significant shareholders, aligns most closely with the 'Director's Dealing' category (DIRS). Although it is a regulatory filing, DIRS is a more specific classification than the general RNS fallback.
2018-07-10 English
Form 8.3 - Carclo PLC
M&A Activity Classification · 98% confidence The document is explicitly titled 'FORM 8.3 - Carclo PLC' and references 'Rule 8.3 of the Takeover Code (the “Code”)'. This form is a 'PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE'. This type of disclosure relates directly to transactions or holdings during a takeover or merger situation. Among the provided categories, 'M&A Activity (Code: TAR)' is the most appropriate classification as it covers announcements and documents related to merger proposals or takeover bids, which necessitates these specific takeover code disclosures.
2018-07-10 English
Form 8.3 - Carclo plc
Regulatory Filings Classification · 98% confidence The document is explicitly labeled as 'FORM 8.3' and references 'Rule 8.3 of the Takeover Code (the "Code")'. It details a 'PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE' concerning an offeror/offeree ('Carclo plc'). This type of disclosure relates to insider/major shareholder dealings during a takeover scenario. While it involves director/executive transactions (which might suggest DIRS), the specific context of a Takeover Code disclosure (Form 8.3) is a specialized regulatory filing related to ownership changes during a bid. Since there is no specific code for 'Takeover Disclosure', and it is a mandatory regulatory filing disseminated via RNS, it fits best under the general 'Regulatory Filings' (RNS) category, as it is not a standard Director's Dealing report (DIRS) which usually refers to Form 3/4/5 equivalents or general insider trading reports outside of a formal takeover context. However, looking closely at the provided definitions, 'Director's Dealing' (DIRS) is defined as 'Report of personal share transactions by company directors and executives (insider trades)'. A Form 8.3 is a specific type of insider disclosure during a takeover. Given the options, RNS is the most appropriate fallback for a specific regulatory form not explicitly listed, but DIRS is also a strong candidate if we interpret 'insider trades' broadly. Since this is a mandatory disclosure under the Takeover Code, RNS (General regulatory announcements and fallback category) is the safest classification for a specific, non-standard regulatory form.
2018-07-09 English
Form 8.3 - Carclo plc
Regulatory Filings Classification · 98% confidence The document is explicitly labeled as an 'RNS Number' and contains the header 'FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE' which references 'Rule 8.3 of the Takeover Code'. This type of disclosure relates to insider/significant shareholder dealings during a takeover scenario. While 'Director's Dealing' (DIRS) is related, Form 8.3 is a specific regulatory filing under the Takeover Code, often disseminated via an RNS service. Since the document details specific positions and dealings related to a potential takeover ('Carclo plc'), it falls under the category of regulatory disclosure concerning share ownership/transactions. Given the options, 'Director's Dealing' (DIRS) is the closest fit for insider/significant shareholder transaction reporting, although 'Regulatory Filings' (RNS) is also plausible as it is an RNS announcement. However, DIRS specifically covers personal share transactions by directors/executives, and Form 8.3 is a mandatory disclosure of interests/dealings by a person holding 1% or more during an offer period, which aligns strongly with the intent of DIRS, even if it's a specific takeover form. I will classify it as DIRS due to the nature of the disclosure (dealing/position disclosure) rather than the general RNS fallback, as DIRS is more specific to the content type.
2018-07-09 English
Form 8 (OPD) - CONSORT MEDICAL PLC
Major Shareholding Notification Classification · 99% confidence The document is clearly identified by the header 'RNS Number : 7428T' and contains specific regulatory language related to corporate actions, namely 'PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER' under 'Rules 8.1 and 8.2 of the Takeover Code (the "Code")'. This type of mandatory disclosure regarding interests in securities during a takeover bid is a specific regulatory filing. Since it is a formal, required disclosure disseminated via RNS (Regulatory News Service), and it doesn't fit the specific categories like Director's Dealing (DIRS) or M&A Activity (TAR) which are broader, the most appropriate classification for a specific, mandatory regulatory filing that isn't a standard financial report (10-K, IR, ER) is the general Regulatory Filings category (RNS), as it is explicitly distributed through that service and concerns compliance with the Takeover Code.
2018-07-05 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.